FDA Watch: Greenlights for NGS Tumor Panels May Augur New Approach to LDT Approvals—Both Product & Pathway
From - Laboratory Industry Report A pair of tumor tests highlights the list of new FDA approvals from mid-November through December, including… . . . read more
This content is exclusive to Lab Industry Report subscribers
Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.